Search Results - "Jensen, Holly A"

  • Showing 1 - 15 results of 15
Refine Results
  1. 1

    6-Formylindolo(3,2-b)Carbazole (FICZ) Modulates the Signalsome Responsible for RA-Induced Differentiation of HL-60 Myeloblastic Leukemia Cells by Bunaciu, Rodica P, Jensen, Holly A, MacDonald, Robert J, LaTocha, Dorian H, Varner, Jeffrey D, Yen, Andrew

    Published in PloS one (19-08-2015)
    “…6-Formylindolo(3,2-b)carbazole (FICZ) is a photoproduct of tryptophan and an endogenous high affinity ligand for aryl hydrocarbon receptor (AhR). It was…”
    Get full text
    Journal Article
  2. 2

    Retinoic acid therapy resistance progresses from unilineage to bilineage in HL-60 leukemic blasts by Jensen, Holly A, Bunaciu, Rodica P, Ibabao, Christopher N, Myers, Rebecca, Varner, Jeffrey D, Yen, Andrew

    Published in PloS one (12-06-2014)
    “…Emergent resistance can be progressive and driven by global signaling aberrations. All-trans retinoic acid (RA) is the standard therapeutic agent for acute…”
    Get full text
    Journal Article
  3. 3

    The Src-family kinase inhibitor PP2 rescues inducible differentiation events in emergent retinoic acid-resistant myeloblastic leukemia cells by Jensen, Holly A, Styskal, Lauren E, Tasseff, Ryan, Bunaciu, Rodica P, Congleton, Johanna, Varner, Jeffrey D, Yen, Andrew

    Published in PloS one (15-03-2013)
    “…Retinoic acid is an embryonic morphogen and dietary factor that demonstrates chemotherapeutic efficacy in inducing maturation in leukemia cells. Using HL60…”
    Get full text
    Journal Article
  4. 4

    iCoreDrop: A robust immune monitoring spectral cytometry assay with six open channels for biomarker flexibility by Jensen, Holly A., Kim, Jeong

    Published in Cytometry. Part A (01-05-2023)
    “…Recent advances in spectral cytometry have extended our ability to monitor immune cell subsets and activation status while simultaneously improving rare…”
    Get full text
    Journal Article
  5. 5

    Analytical performance of a 25‐marker spectral cytometry immune monitoring assay in peripheral blood by Jensen, Holly A., Wnek, Richard

    Published in Cytometry. Part A (01-02-2021)
    “…Herein, we describe the development and analytical performance characteristics of a spectral flow cytometry assay for longitudinal immune monitoring biomarker…”
    Get full text
    Journal Article
  6. 6

    Induced myelomonocytic differentiation in leukemia cells is accompanied by noncanonical transcription factor expression by Jensen, Holly A., Yourish, Harmony B., Bunaciu, Rodica P., Varner, Jeffrey D., Yen, Andrew

    Published in FEBS open bio (01-01-2015)
    “…•We surveyed common myeloid leukemia cell lines undergoing differentiation therapy.•Lineage progression in induced leukemia cell lines differs from…”
    Get full text
    Journal Article
  7. 7

    An Effective Model of the Retinoic Acid Induced HL-60 Differentiation Program by Tasseff, Ryan, Jensen, Holly A., Congleton, Johanna, Dai, David, Rogers, Katharine V., Sagar, Adithya, Bunaciu, Rodica P., Yen, Andrew, Varner, Jeffrey D.

    Published in Scientific reports (30-10-2017)
    “…In this study, we present an effective model All-Trans Retinoic Acid (ATRA)-induced differentiation of HL-60 cells. The model describes reinforcing feedback…”
    Get full text
    Journal Article
  8. 8

    GW5074 and PP2 kinase inhibitors implicate nontraditional c-Raf and Lyn function as drivers of retinoic acid-induced maturation by Jensen, Holly A., Bunaciu, Rodica P., Varner, Jeffrey D., Yen, Andrew

    Published in Cellular signalling (01-08-2015)
    “…The multivariate nature of cancer necessitates multi-targeted therapy, and kinase inhibitors account for a vast majority of approved cancer therapeutics. While…”
    Get full text
    Journal Article
  9. 9

    Retinoic acid and 6-formylindolo(3,2-b)carbazole (FICZ) combination therapy reveals putative targets for enhancing response in non-APL AML by Bunaciu, Rodica P., MacDonald, Robert J., Jensen, Holly A., Gao, Feng, Wang, Xin, Johnson, Lynn, Varner, Jeffrey D., Yen, Andrew

    Published in Leukemia & lymphoma (07-06-2019)
    “…In non-acute promyelotic leukemia (APL)- non myelocytic leukemia (AML), identification of a signaling signature would predict potentially actionable targets to…”
    Get full text
    Journal Article
  10. 10
  11. 11

    6-Formylindolo Modulates the Signalsome Responsible for RA-Induced Differentiation of HL-60 Myeloblastic Leukemia Cells by Bunaciu, Rodica P, Jensen, Holly A, MacDonald, Robert J, LaTocha, Dorian H, Varner, Jeffrey D, Yen, Andrew

    Published in PloS one (19-08-2015)
    “…6-Formylindolo(3,2-b)carbazole (FICZ) is a photoproduct of tryptophan and an endogenous high affinity ligand for aryl hydrocarbon receptor (AhR). It was…”
    Get full text
    Journal Article
  12. 12

    6-Formylindolo by Bunaciu, Rodica P, Jensen, Holly A, MacDonald, Robert J, LaTocha, Dorian H, Varner, Jeffrey D, Yen, Andrew

    Published in PloS one (19-08-2015)
    “…6-Formylindolo(3,2-b)carbazole (FICZ) is a photoproduct of tryptophan and an endogenous high affinity ligand for aryl hydrocarbon receptor (AhR). It was…”
    Get full text
    Journal Article
  13. 13

    Overcoming the differentiation block: Mechanisms of retinoic acid-induced differentiation, resistance, and lineage selection in myeloid leukemia progenitor cells by Jensen, Holly A

    Published 01-01-2015
    “…Differentiation induction therapy aims to “reform, rather than retaliate” like conventional chemotherapeutic methods. The most successful differentiation…”
    Get full text
    Dissertation
  14. 14

    6-Formylindolo(3,2-b)Carbazole (FICZ) Modulates the Signalsome Responsible for RA-Induced Differentiation of HL-60 Myeloblastic Leukemia Cells: e0135668 by Bunaciu, Rodica P, Jensen, Holly A, MacDonald, Robert J, LaTocha, Dorian H, Varner, Jeffrey D, Yen, Andrew

    Published in PloS one (01-08-2015)
    “…6-Formylindolo(3,2-b)carbazole (FICZ) is a photoproduct of tryptophan and an endogenous high affinity ligand for aryl hydrocarbon receptor (AhR). It was…”
    Get full text
    Journal Article
  15. 15

    The Src-Family Kinase Inhibitor PP2 Rescues Inducible Differentiation Events in Emergent Retinoic Acid-Resistant Myeloblastic Leukemia Cells. e58621 by Jensen, Holly A, Styskal, Lauren E, Tasseff, Ryan, Bunaciu, Rodica P, Congleton, Johanna, Varner, Jeffrey D, Yen, Andrew

    Published in PloS one (01-03-2013)
    “…Retinoic acid is an embryonic morphogen and dietary factor that demonstrates chemotherapeutic efficacy in inducing maturation in leukemia cells. Using HL60…”
    Get full text
    Journal Article